Skip to main content
NHLBIHIN

Archived page

National Cholesterol Education Program

Adult Treatment Panel III (ATP III) Guidelines Slide Set

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 11 | 12 | 13 | 14

Return to Menu



SLIDE 1: ATP III Guidelines
Detection and Evaluation

 Return to Top

SLIDE 2: Categories of Risk Factors

  • Major, independent risk factors
  • Life-habit risk factors
  • Emerging risk factors

 Return to Top

SLIDE 3: Life-Habit Risk Factors

  • Obesity (BMI greater than or equal to30)
  • Physical inactivity
  • Atherogenic diet

 Return to Top

SLIDE 4: Emerging Risk Factors

  • Lipoprotein (a)
  • Homocysteine
  • Prothrombotic factors
  • Proinflammatory factors
  • Impaired fasting glucose
  • Subclinical atherosclerosis

 Return to Top

SLIDE 5: Risk Assessment
Count major risk factors

  • For patients with multiple (2+) risk factors
    • Perform 10-year risk assessment
  • For patients with 0-1 risk factor
    • 10 year risk assessment not required
    • Most patients have 10-year risk <10%

 Return to Top

SLIDE 6: Major Risk Factors (Exclusive of LDL Cholesterol) That Modify LDL Goals

  • Cigarette smoking
  • Hypertension (BP greater than or equal to140/90 mmHg or on antihypertensive medication)
  • Low HDL cholesterol (<40 mg/dL)†
  • Family history of premature CHD
    • CHD in male first degree relative <55 years
    • CHD in female first degree relative <65 years
  • Age (men greater than or equal to45 years; women greater than or equal to55 years)

† HDL cholesterol greater than or equal to60 mg/dL counts as "negative" risk factor; its presence removes one risk factor from the total count.

 Return to Top

SLIDE 7: Diabetes
In ATP III, diabetes is regarded as a CHD risk equivalent.

 Return to Top

SLIDE 8: CHD Risk Equivalents

  • Risk for major coronary events equal to that in established CHD
  • 10-year risk for hard CHD >20%

Hard CHD=myocardial infarction + coronary death

 Return to Top

SLIDE 9: Diabetes as a CHD Risk Equivalent

  • 10-year risk for CHD approximately equal to20%
  • High mortality with established CHD
    • High mortality with acute MI
    • High mortality post acute MI

 Return to Top

SLIDE 10: CHD Risk Equivalents

  • Other clinical forms of atherosclerotic disease (peripheral arterial disease, abdominal aortic aneurysm, and symptomatic carotid artery disease)
  • Diabetes
  • Multiple risk factors that confer a 10-year risk for CHD >20%

 Return to Top

SLIDE 11: Three Categories of Risk that Modify LDL-Cholesterol

Goals Risk Category LDL Goal (mg/dL)
CHD and CHD risk equivalents <100
Multiple (2+) risk factors <130
Zero to one risk factor <160

 Return to Top

SLIDE 12: ATP III Lipid and Lipoprotein Classification
LDL Cholesterol (mg/dL)

  • <100 Optimal
  • 100-129 Near optimal/above optimal
  • 130-159 Borderline high
  • 160-189 High
  • greater than or equal to190 Very high

 Return to Top

SLIDE 13: ATP III Lipid and Lipoprotein Classification (continued)
HDL Cholesterol (mg/dL)

  • <40 Low
  • greater than or equal to60 High

 Return to Top

SLIDE 14: ATP III Lipid and Lipoprotein Classification (continued)
Total Cholesterol (mg/dL)

  • <200 Desirable
  • 200-239 Borderline high
  • greater than or equal to240 High Primary

 Return to Top

Archived page, reproduced from a 2012 copy. It is reference material, not current guidance.